Kimberly-Clark Beats Q1 Earnings Despite Sales Headwinds, Guides for Double-Digit Growth

Kimberly-Clark Corporation (NASDAQ: KMB) delivered first-quarter adjusted earnings of $1.97 per share, up 2.1% from $1.93 in the prior year period, as the consumer products giant navigated a challenging environment with solid volume growth and aggressive cost savings. The maker of Huggies, Kleenex, and Scott brands reported revenue of $4.16 billion, up 2.7% year-over-year, driven by organic sales growth of 2.5%.

Key Numbers

The Dallas-based company's adjusted earnings per share from continuing operations came in at $1.60, down slightly by 1.2% from the prior year, primarily due to a higher effective tax rate of 26.2% versus 20.7% a year ago. However, when including discontinued operations, adjusted EPS reached $1.97, beating the year-ago figure of $1.93.

Revenue growth of 2.7% to $4.16 billion was powered by organic sales expansion of 2.5%, with volume and mix contributing a robust 3.0% gain. This strength was partially offset by strategic pricing investments of 0.5% as the company invested to drive trial of new products and enhance value propositions across its portfolio. Currency translation provided a 2.0% tailwind, while the exit from the private label diaper business created a 1.8% headwind.

Adjusted gross margin compressed 60 basis points to 37.9%, as strong productivity savings were more than offset by the deliberate pricing investments and supply chain investments. Despite the margin pressure, adjusted operating profit rose 3.7% to $732 million, driven by productivity initiatives and lower overhead expenses.

By segment, International Personal Care delivered standout performance with sales up 9.1% and operating profit surging 21.9% to $245 million. The segment saw organic sales growth of 4.0%, led by volume gains of 4.1% and improved mix of 1.4%. North America sales declined 0.6% to $2.7 billion, though this reflected the private label diaper exit – underlying organic growth was a healthy 1.8%.

What Management Said

CEO Mike Hsu struck an optimistic tone, emphasizing the company's momentum heading into its pending acquisition of Kenvue. "Our first quarter results highlight the strength and resilience of the growth engine we've built through Powering Care," Hsu stated. "We continued to deliver solid volume-plus-mix performance while building share momentum despite continued geopolitical and macroeconomic uncertainty."

Management highlighted that the company achieved its results "by driving consumer-inspired innovation, growing brand love, and executing exceptionally well as a team." Hsu specifically called out "one of the strongest innovation and commercial activation lineups in our history set to launch in the second quarter."

On the pending Kenvue acquisition, which will transform Kimberly-Clark into a broader health and hygiene company, Hsu expressed confidence: "We're preparing Kimberly-Clark to unlock the unique, generational value creation opportunity ahead with the acquisition of Kenvue... we're excited to accelerate into our next chapter and build a company unlike any other in our industry today."

The company reaffirmed its 2026 outlook, expecting organic sales growth to match or exceed category growth of approximately 2.5%. Management guided for adjusted operating profit to grow at a mid-to-high single-digit rate on a constant-currency basis, while adjusted EPS from continuing operations is expected to grow at a double-digit rate, aided by a 40% increase in income from equity companies.

What to Watch

Several key factors will shape Kimberly-Clark's trajectory through the remainder of 2026. The pending Kenvue acquisition represents the most significant strategic shift, potentially creating substantial synergies but also integration risks. The company will need to execute this complex transaction while maintaining operational momentum in its core business.

The company's deliberate pricing strategy bears monitoring. While the 0.5% price reduction in Q1 helped drive volume growth, it pressured margins. Investors should watch whether this trade-off continues to generate market share gains and if the company can offset margin pressure through its productivity programs, which delivered strong results in the quarter.

The International Personal Care segment's exceptional 21.9% operating profit growth demonstrates the power of Kimberly-Clark's emerging markets strategy. With 4.1% volume growth in these markets, the segment is clearly gaining traction and could become an increasingly important growth driver, especially as currency headwinds potentially moderate.

Cash generation improved markedly with operating cash flow of $745 million versus $327 million in the prior year, though capital spending also doubled to $424 million. The company's ability to fund both the Kenvue acquisition and maintain its dividend (currently yielding approximately 3.5%) while investing in growth will be critical.

The expected mid-2026 close of the International Family Care and Professional business sale to Suzano will provide proceeds to partially fund the Kenvue deal. However, this will also reduce earnings from discontinued operations, creating a headwind that management has already factored into guidance.

With strong innovation launches planned for Q2 and productivity programs delivering results, Kimberly-Clark appears well-positioned to navigate near-term challenges while executing its transformational acquisition strategy. The key question for investors is whether the company can successfully integrate Kenvue while maintaining the operational excellence that drove Q1's solid performance.

*StockCliff Research*